Yahoo Finance

Auron Therapeutics Announces FDA Clearance to Initiate Clinical Development of AUTX-703 and Completion of Series B Financing

NEWTON, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory ...
Yahoo Finance

Auron Strengthens Board of Directors and Leadership Team with Industry Veterans, Victoria Richon, Ph.D. and Christopher Guiffre, J.D., MBA

NEWTON, Mass., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Auron Therapeutics, a platform-based, product-driven biotechnology company focused on discovering and developing novel cancer therapies using its ...
The Business Journals

Biotech raises Series B to test cancer drug in the clinic

Kate Yen is the founder and CEO of Auron Therapeutics. From the Boston Business Journal. Auron Therapeutics has raised a $27 million Series B financing that it will use to initiate clinical ...
The Business Journals

Newton biotech raises Series B to test cancer drug in the clinic

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Auron Therapeutics has raised a ...